Clinical Trials List
Protocol NumberC14013
2012-06-01 - 2013-12-31
Phase I
Terminated2
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ann-Lii Cheng Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- YEN-SHEN LU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jin-Hwang Liu Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Mu-Hsin Chang Division of Hematology & Oncology
- Muh-Hwa Yang Division of Hematology & Oncology
- 余垣斌 Division of Hematology & Oncology
- 曾成槐 Division of Hematology & Oncology
- Ta-Chung Chao Division of Hematology & Oncology
- 洪英中 Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- Hao-Wei Teng Division of Hematology & Oncology
- Chun-Yu Liu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
30 participants
